Get to know the RNA-seq Analysis Portal, a cloud-based platform you can access from within QIAGEN Ingenuity Pathway Analysis (IPA) that helps you analyze your RNA-seq expression data. Its predefined […]
Back by popular demand, our live, interactive HGMD Professional sessions are designed to help you master the skills needed to navigate and use the industry-leading database like an expert. This […]
This webinar will introduce users to the long read support plugin for Oxford Nanopore and PacBio sequencing reads in QIAGEN CLC Genomics Workbench. Participants will learn how to: Download and […]
Meet QIAGEN at the Precision Medicine Forum Berlin This year at the 2024 Precision Medicine Forum Berlin, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA […]
Meet QIAGEN at the 2024 American Society of Human Genetics (ASHG) Annual Meeting This year at the 2024 American Society of Human Genetics (ASHG) Annual Meeting, QIAGEN will showcase our Sample […]
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries […]
An exclusive hands-on workshop to try QCI Interpret for Oncology For US-based labs interested in learning more about QCI Interpret for Oncology, QIAGEN’s clinical decision support software for variant interpretation […]
Join us for a 90-minute LIVE group session designed to address different technical questions regarding IPA certification. QIAGEN IPA scientists will answer different IPA related technical questions and clarify various […]
Learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers, validate targets, and identify variants. Attendees will learn to: Locate public studies of interest using OmicSoft DiseaseLand Investigate […]
Each year, more than 134 million patients experience adverse drug events, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer, more effective […]
While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such investigation is hindered by the difficulty in finding and combining […]
Meet QIAGEN at the 2024 Association for Molecular Pathology (AMP) Annual Meeting This year at the 2024 Association for Molecular Pathology (AMP) Annual Meeting, QIAGEN will showcase our barrier-breaking Sample to […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships […]
Watch Now
